1122301

Jeffrey G. Leflein, M.D. — FEI 3001452115

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 20, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ypsilanti, MI (United States)

Additional Details

Clinical Investigator (CI)